Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2025-02-21 5:42 pm Sale |
2024-12-31 | 13G | Omeros Corporation OMER |
INGALLS & SNYDER LLC | 4,161,315 7.200% |
-269,873 (-6.09%) |
Filing History |
| 2025-02-21 5:37 pm Purchase |
2024-12-31 | 13G | DURECT Corporation DRRX |
INGALLS & SNYDER LLC | 2,681,770 8.500% |
123,758 (+4.84%) |
Filing History |
| 2025-02-21 5:23 pm Sale |
2024-12-31 | 13G | Corcept Therapeutics Incorporated CORT |
INGALLS & SNYDER LLC | 8,173,721 7.800% |
-88,755 (-1.07%) |
Filing History |
| 2025-02-21 3:41 pm Purchase |
2024-12-31 | 13G | Stratus Properties Inc. STRS |
INGALLS & SNYDER LLC | 1,092,084 13.500% |
111,027 (+11.32%) |
Filing History |
| 2025-02-14 5:17 pm Sale |
2024-12-31 | 13G | Applied Energetics, Inc. AERG |
INGALLS & SNYDER LLC | 18,158,048 8.200% |
-422,188 (-2.27%) |
Filing History |
| 2024-03-27 3:15 pm Purchase |
2023-12-31 | 13G | DURECT Corporation DRRX |
INGALLS & SNYDER LLC | 2,558,012 8.600% |
2,558,012 (New Position) |
Filing History |
| 2024-03-27 3:12 pm Sale |
2005-12-31 | 13G | Stratus Properties Inc. STRS |
INGALLS & SNYDER LLC | 981,057 12.300% |
-126,983 (-11.46%) |
Filing History |
| 2024-03-27 2:47 pm Purchase |
2023-12-31 | 13G | Omeros Corporation OMER |
INGALLS & SNYDER LLC | 4,431,188 7.000% |
299,395 (+7.25%) |
Filing History |
| 2024-03-27 2:43 pm Sale |
2023-12-31 | 13G | Applied Energetics, Inc. AERG |
INGALLS & SNYDER LLC | 18,580,236 8.800% |
-6,477,729 (-25.85%) |
Filing History |
| 2024-03-27 2:32 pm Purchase |
2023-12-31 | 13G | Corcept Therapeutics Incorporated CORT |
INGALLS & SNYDER LLC | 8,262,476 8.000% |
1,172,106 (+16.53%) |
Filing History |
| 2024-02-27 10:33 am Purchase |
2024-02-13 | 13G | ImmunoPrecise Antibodies Ltd. IPA |
INGALLS & SNYDER LLC | 1,317,819 5.010% |
264,633 (+25.13%) |
Filing History |
| 2023-07-07 3:22 pm Purchase |
2023-06-29 | 13D | ImmunoPrecise Antibodies Ltd. IPA |
INGALLS & SNYDER LLC | 1,053,186 4.220% |
1,053,186 (New Position) |
Filing History |
| 2023-02-17 5:11 pm Sale |
2005-12-31 | 13G | Stratus Properties Inc. STRS |
INGALLS & SNYDER LLC | 1,108,040 13.500% |
-51,026 (-4.40%) |
Filing History |
| 2023-02-17 5:07 pm Sale |
2022-12-31 | 13G | Omeros Corporation OMER |
INGALLS & SNYDER LLC | 4,131,793 6.600% |
-332,699 (-7.45%) |
Filing History |
| 2023-02-17 4:59 pm Purchase |
2022-12-31 | 13G | Corcept Therapeutics Incorporated CORT |
INGALLS & SNYDER LLC | 7,090,370 6.600% |
434,393 (+6.53%) |
Filing History |
| 2023-02-17 4:49 pm Purchase |
2022-12-31 | 13G | Applied Energetics, Inc. AERG |
INGALLS & SNYDER LLC | 25,057,965 12.100% |
8,193,861 (+48.59%) |
Filing History |
| 2022-02-04 07:22 am Purchase |
2021-12-31 | 13G | Applied Energetics, Inc. AERG |
INGALLS & SNYDER LLC | 16,864,104 8.100% |
16,864,104 (New Position) |
Filing History |
| 2022-02-04 07:17 am Sale |
2005-12-31 | 13G | Stratus Properties Inc. STRS |
INGALLS & SNYDER LLC | 1,159,066 14.000% |
-80,830 (-6.52%) |
Filing History |
| 2022-02-04 07:14 am Sale |
2021-12-31 | 13G | Omeros Corporation OMER |
INGALLS & SNYDER LLC | 4,464,492 7.100% |
-283,697 (-5.97%) |
Filing History |
| 2022-02-04 07:11 am Sale |
2021-12-31 | 13G | Corcept Therapeutics Incorporated CORT |
INGALLS & SNYDER LLC | 6,655,977 5.700% |
-927,795 (-12.23%) |
Filing History |